Ergocalciferol
Hypoparathyroidism, dietary supplementation, Phosphaturia + 3 more
Treatment
6 FDA approvals
5 Active Studies for Ergocalciferol
Treatment for
Hypoparathyroidism
What is Ergocalciferol
Ergocalciferol
The Generic name of this drug
Treatment Summary
Ergocalciferol is a form of vitamin D analog. It is produced in plants when exposed to UVB light, and was discovered in 1931. Ergocalciferol is different from other forms of vitamin D because it has a double bond between two carbon atoms and a methyl group in a specific place. This makes it easier for the body to clear the vitamin D, and it also affects how the body breaks down the vitamin D. Ergocalciferol was approved for use by the FDA in 1941.
Drisdol
is the brand name
Ergocalciferol Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Drisdol
Ergocalciferol
1974
97
Approved as Treatment by the FDA
Ergocalciferol, also called Drisdol, is approved by the FDA for 6 uses which include Rickets and Phosphaturia .
Rickets
Phosphaturia
Hypoparathyroidism
Hypoparathyroidism
Vitamin D Resistant Rickets
Hypophosphatemia, Familial
Effectiveness
How Ergocalciferol Affects Patients
Ergocalciferol is a form of vitamin D that helps the body absorb calcium and phosphorus from food, as well as aiding in fetal development, immune function, and cell growth and differentiation. Compared to cholecalciferol, another form of vitamin D, ergocalciferol has a weaker effect. People with end-stage kidney disease have been shown to benefit from taking ergocalciferol, as it helps improve their bone and mineral metabolism, blood sugar levels, and inflammation.
How Ergocalciferol works in the body
Ergocalciferol is the active form of vitamin D. It needs to be changed in the body to work properly, and transported to certain organs so it can bind to its target, the vitamin D receptor. This binding has two effects: it changes how certain genes act, and it stimulates calcium transport in the intestines.
When to interrupt dosage
The suggested dosage of Ergocalciferol is contingent upon the recognized condition, including dietary supplementation, Phosphaturia and Deficiency, Vitamin A. The measure of dosage differs, in accordance with the technique of delivery (e.g. Oral or Liquid) indicated in the table beneath.
Condition
Dosage
Administration
Vitamin A Deficiency
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
Hypoparathyroidism
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
dietary supplementation
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
Phosphaturia
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
Vitamin D Deficiency
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
Rickets
, 1.25 mg, 50000.0 units, 200.0 units, 400.0 units, 135.0 units, 100.0 units, 2000.0 units, 125.0 units, 8000.0 units/mL, 100.0 mg, 0.01 mg/mL, 400.0 [iU], 0.005 mg/mL, 0.2 mg/mL, 500.0 [iU], 8000.0 [iU]/mL, 1000.0 units, 200.0 units/mL, 40.0 units/mL, 4000.0 units/mL, 666.0 units/mL, 80.0 units/mL, 2.0 units/mL
, Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Capsule - Oral, Capsule, Tablet - Oral, Solution / drops - Oral, Solution / drops, Tablet, Liquid, Liquid - Oral, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Parenteral, Solution - Parenteral, Solution - Oral, Injection, powder, lyophilized, for solution, Kit, Liquid - Intravenous, Syrup - Oral, Syrup, Tablet, effervescent - Oral, Tablet, effervescent, Tablet, extended release - Oral, Tablet, extended release
Warnings
Ergocalciferol Contraindications
Condition
Risk Level
Notes
Malabsorption Syndrome
Do Not Combine
Hypercalcemia
Do Not Combine
Hypervitaminosis D
Do Not Combine
Hypersensitivity
Do Not Combine
There are 20 known major drug interactions with Ergocalciferol.
Common Ergocalciferol Drug Interactions
Drug Name
Risk Level
Description
Sucralfate
Major
The serum concentration of Sucralfate can be increased when it is combined with Ergocalciferol.
1alpha,24S-Dihydroxyvitamin D2
Moderate
The risk or severity of adverse effects can be increased when Ergocalciferol is combined with 1alpha,24S-Dihydroxyvitamin D2.
1alpha-Hydroxyvitamin D5
Moderate
The risk or severity of adverse effects can be increased when Ergocalciferol is combined with 1alpha-Hydroxyvitamin D5.
Acetyldigitoxin
Moderate
The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Acetyldigitoxin.
Acetyldigoxin
Moderate
The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Acetyldigoxin.
Ergocalciferol Toxicity & Overdose Risk
An overdose of ergocalciferol can cause hypervitaminosis, leading to high calcium levels, weakened kidney function, calcification of the tissues, slower growth, and increased bone mineralization. To treat an overdose, vitamin D should be stopped and a calcium-rich diet should be consumed along with plenty of fluids. Loop diuretics may be used to increase calcium excretion, while dialysis and other treatments may be recommended as well. There have not yet been any long-term studies on the cancer-causing or gene-altering effects of ergocalciferol or its effects on fertility.
Ergocalciferol Novel Uses: Which Conditions Have a Clinical Trial Featuring Ergocalciferol?
Presently, 6 clinical trials are under way to assess the potential of Ergocalciferol to supplement diets, ameliorate Hypoparathyroidism and reduce Phosphaturia.
Condition
Clinical Trials
Trial Phases
dietary supplementation
0 Actively Recruiting
Rickets
2 Actively Recruiting
Early Phase 1, Not Applicable
Hypoparathyroidism
3 Actively Recruiting
Not Applicable, Phase 2, Phase 1
Vitamin D Deficiency
0 Actively Recruiting
Phosphaturia
0 Actively Recruiting
Vitamin A Deficiency
0 Actively Recruiting
Ergocalciferol Reviews: What are patients saying about Ergocalciferol?
5
Patient Review
7/1/2017
Ergocalciferol for Vitamin D Deficiency (High Dose Therapy)
5
Patient Review
5/14/2015
Ergocalciferol for Vitamin D Deficiency (High Dose Therapy)
3.7
Patient Review
5/17/2019
Ergocalciferol for Osteoporosis
3.7
Patient Review
2/1/2013
Ergocalciferol for Vitamin D Deficiency
3.7
Patient Review
4/14/2019
Ergocalciferol for Vitamin D Deficiency
3
Patient Review
3/17/2022
Ergocalciferol for Vitamin D Deficiency
3
Patient Review
2/2/2014
Ergocalciferol for Vitamin D Deficiency
2.7
Patient Review
7/21/2015
Ergocalciferol for Vitamin D Deficiency (High Dose Therapy)
2.7
Patient Review
11/2/2013
Ergocalciferol for Osteoporosis
2.3
Patient Review
1/6/2017
Ergocalciferol for Vitamin D Deficiency
2.3
Patient Review
6/1/2017
Ergocalciferol for Vitamin D Deficiency (High Dose Therapy)
2
Patient Review
6/16/2016
Ergocalciferol for Vitamin D Deficiency (High Dose Therapy)
1
Patient Review
3/12/2021
Ergocalciferol for Prevention of Vitamin D Deficiency
1
Patient Review
1/3/2015
Ergocalciferol for Vitamin D Deficiency
Patient Q&A Section about ergocalciferol
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is ergocalciferol same as vitamin D3?
"Vitamin D3 is created in the human body in response to sunlight, and is also available through dietary sources, such as fish. Vitamin D2 is not created in the human body, but is made by exposing certain plant-derived materials to ultraviolet light."
Answered by AI
What is ergocalciferol used to treat?
"Ergocalciferol is used to treat a lack of parathyroid hormone, refractory rickets, and a familial form of rickets or osteomalacia."
Answered by AI
What is ergocalciferol side effects?
"Ergocalciferol may cause chest pain, feeling short of breath, growth problems in children, or early signs of vitamin d overdose such as weakness, metallic taste in your mouth, weight loss, muscle or bone pain, constipation, nausea, and vomiting."
Answered by AI